Fees under new Medical Device Regulation: Council of EU paints a different picture
This article was originally published in Clinica
Executive Summary
A detailed analysis of the Council of the EU’s recently published amendments to the proposed Medical Device Regulation reveals that the council’s views on fees which manufacturers have to pay to meet the new requirements diverge significantly from those of the European Commission. The council is also wanting EU “expert panels” and “expert laboratories” to take over the role of existing EU reference laboratories but with slightly different responsibilities.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.